CHRW vs RXO
C. H. Robinson Worldwide, Inc. and Rxo, Inc., side by side — 6 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CHRW | RXO |
|---|---|---|
| Revenue | $16.2B | $5.7B |
| Net income | $587.1M | $-100.0M |
| Gross margin | · | 19.7% |
| Net margin | 3.6% | −1.7% |
| Return on equity | 32.9% | −6.3% |
| Diluted EPS | $4.83 | −$0.59 |
| Dividend / share | $2.49 | · |
| Payout ratio | 51.3% | · |
| Free cash flow | $894.9M | $-8.0M |
| Equity | $1.8B | $1.5B |
| Net debt / equity | 0.50× | 0.25× |
| Current ratio | 1.53× | 1.27× |
| Revenue CAGR 5y | 0.0% | 11.3% |
| Profit CAGR 5y | 3.0% | · |
CHRW bills 2.8× the revenue of RXO, and RXO closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
6 years side by side
| Fiscal year | CHRW | RXO |
|---|---|---|
| FY2025 | $16.2B | $5.7B |
| FY2024 | $17.7B | $4.5B |
| FY2023 | $17.6B | $3.9B |
| FY2022 | $24.7B | $4.8B |
| FY2021 | $23.1B | $4.7B |
| FY2020 | $16.2B | $3.4B |
Bottom line
| Fiscal year | CHRW | RXO |
|---|---|---|
| FY2025 | $587.1M | $-100.0M |
| FY2024 | $465.7M | $-290.0M |
| FY2023 | $325.1M | $4.0M |
| FY2022 | $940.5M | $92.0M |
| FY2021 | $844.2M | $150.0M |
| FY2020 | $506.4M | $43.0M |
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$10,490,763,000 | CHRW |
| FY2024 | +$13,174,956,000 | CHRW |
| FY2023 | +$13,669,443,000 | CHRW |
| FY2022 | +$19,900,625,000 | CHRW |
| FY2021 | +$18,413,138,000 | CHRW |
| FY2020 | +$12,850,106,000 | CHRW |
CHRW has reported the higher revenue in every one of these 6 fiscal years. The gap has narrowed since the earliest year compared.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +5.4 pp | CHRW |
| FY2024 | +9.0 pp | CHRW |
| FY2023 | +1.7 pp | CHRW |
| FY2022 | +1.9 pp | CHRW |
| FY2021 | +0.5 pp | CHRW |
| FY2020 | +1.8 pp | CHRW |
CHRW has kept the higher net margin in every one of these 6 fiscal years.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
RXO's net margin has been more volatile than CHRW's over the 6 comparable fiscal years — 3.1 percentage points of standard deviation against 0.7.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
CHRW led in net margin in every one of the 6 comparable fiscal years — a structural lead, not a recent swing.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
RXO's return on equity has been more volatile than CHRW's over the 6 comparable fiscal years — 13.3 percentage points of standard deviation against 10.8.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
CHRW led in return on equity in every one of the 6 comparable fiscal years — a structural lead, not a recent swing.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.